Thu, October 1, 2020
Wed, September 30, 2020
Tue, September 29, 2020
Mon, September 28, 2020
Sat, September 26, 2020
Fri, September 25, 2020
Thu, September 24, 2020
Wed, September 23, 2020
Tue, September 22, 2020
Mon, September 21, 2020
Sun, September 20, 2020
Fri, September 18, 2020
Thu, September 17, 2020
Wed, September 16, 2020
Tue, September 15, 2020

Michael Schmitz Maintained (BPMC) at Strong Buy with Increased Target to $106 on, Sep 23rd, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-106-on-sep-23rd-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Schmitz of Guggenheim, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $94 to $106 on, Sep 23rd, 2020.

Michael has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 0 agree with Michael's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Michael


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $107 on, Monday, July 27th, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, July 15th, 2020
  • Konstantinos Aprilakis of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $85 on, Monday, June 8th, 2020

Publication Contributing Sources